ArticleJournal of psychopharmacology (Oxford, England)2023
Characteristics of poisonings involving ketamine in the United States, 2019-2021.
Article in Journal of psychopharmacology (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 33 citations in OpenAlex.
- Unintentional ingestion of recreational drugs among young children, 2000-2024.BMC public health · 2026Article
- Grayken lessons: a multidisciplinary approach to care for a patient with severe ketamine use disorder.Addiction science & clinical practice · 2026Article
- Street ketamine use and differential risk of suicidality among adults in Taiwan.Harm reduction journal · 2025Article
- Ketamine Hepatotoxicity: An Underappreciated Cause of Liver Damage - Analysis by RUCAM.Journal of clinical and translational hepatology · 2025Article
- Ketamine Versus Electroconvulsive Therapy for the Treatment of Depression: A Guide for Clinicians.Focus (American Psychiatric Publishing) · 2025Article
- Trends and characteristics in ketamine use among US adults with and without depression, 2015-2022.Journal of affective disorders · 2025Article
- Trends in poisonings involving ketamine in the United States, 2019-2023.Drug and alcohol dependence · 2025Article
- Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?The American journal of psychiatry · 2025Review
- Treadmill Exercise Training Ameliorates Apoptotic Cells and DNA Oxidation in the Cerebral Cortex of Rats Exposed to Chronic Ketamine Abuse.Addiction biology · 2025Article
- Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment.Journal of psychopharmacology (Oxford, England) · 2025Article
- Nonfatal pediatric fentanyl exposures reported to US poison centers, 2015-2023.The American journal of drug and alcohol abuse · 2025Article
- An Update on the Epidemiology of Tusi ("Pink Cocaine").Current addiction reports · 2025Article
- The Rapidly Shifting Ketamine Landscape in the US.JAMA psychiatry · 2024Article
- Trends in reported and biologically confirmed drug use among people who use ecstasy in the nightclub/festival-attending population, 2016-2022.Drug and alcohol dependence reports · 2023Article
- Prevalence of self-reported adverse effects associated with drug use among nightclub and festival attendees, 2019-2022.Drug and alcohol dependence reports · 2023Article
- Trends in drug use among nightclub and festival attendees in New York City, 2017-2022.The International journal on drug policy · 2023Article
Corrections and comments
- Commented on by
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundThe use of ketamine, a controlled dissociative anesthetic, has become more widespread in recent years with recreational/nonmedical use increasing and ketamine becoming more widely available in clinics to treat depression.
aimsWe examined recent trends in adverse effects related to ketamine use.
methodsUS National Poison Control data were examined, focusing on ketamine exposures among those aged ⩾13 between 2019 and 2021 (
resultsThe number of reported exposures increased 81.1% from 2019 Quarter 1 through 2021 Quarter 4, from 37 to 67 (
conclusionsAlthough still rare, poisonings involving ketamine have increased in recent years. Polydrug use-particularly with opioids or GHB-appears to be a particular risk factor for more serious adverse effects. As prevalence of use increases, it is important to monitor adverse effects and co-occurring behaviors to inform timely prevention and harm reduction as needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.